| Date | Title | Description |
| 10.09.2026 | Claret Capital Secures €575M for European Tech, Life Sciences Growth | Claret Capital Partners has finalized its €575 million Fund IV. This significant growth debt fund targets Europe's burgeoning technology and life sciences sectors. It provides flexible, non-dilutive capital. The firm exceeded its €500 milli... |
| 07.09.2026 | Claret Capital Partners exceeds target with €575M growth debt fund for European innovators | Claret Capital Partners has closed its fourth European Growth Capital Fund at €575 million, exceeding its €500 million target. Including affiliated discretionary mandates, the fund will make growth debt investments in technology, life scien... |
| 07.09.2026 | Claret Capital Partners Raises €575M for European Growth | Claret Capital Partners Closes €575M Fund IV
London-based Claret Capital Partners has raised €575 million through Fund IV and an affiliated discretionary mandate. This surpassed its original €500 million fundraising target. The firm complet... |
| 06.03.2026 | University spinouts boom as startups pull in billions | Academics are increasingly going on to start their own start-ups, with a surge in spinouts, patents and investment pointing to the growing commercial impact of Britain’s research base.
New figures seen by City AM show the number of UCL acad... |
| 13.04.2023 | Tech.eu Summit 2023: Announcing 10 new speakers, last chance to get early-bird tickets, and startups should apply now! | A little over 40 days to go before the next edition of our flagship event on all things European tech startups and VC, and the Tech.eu Summit is shaping up quuuuuuite nicely thank you very much.
Today, we're thrilled to reveal the 10 latest... |
| 21.10.2021 | MedStar Montgomery Medical Center Introduces Magseed Technology to Montgomery County, Improving the Standard of Cancer Care | "We are proud to bring the most innovative and effective treatments to our patients right here in Montgomery County. The addition of the Magseed marking technology advances our goal to provide the most comprehensive, compassionate and ... |
| 01.12.2020 | Improving breast cancer care: UK-based medtech startup Endomag secures €16.73M in series D funding | Almost every sector has been enriched with the use of modern technology, and healthcare is no different. There are numerous medtech or health tech startups that have come up with innovative new solutions to health problems. The UK-based sta... |
| 01.12.2020 | Endomag secures £15 million ($20 million) in Series D funding | Endomag, a breast cancer market leader and one of the UK’s fastest growing private technology businesses1, has secured £15m (~$20m) in Series D funding. These funds are earmarked for expanding access to new advanced techniques enabled by it... |
| 01.12.2020 | Endomag secures £15 million Series D funding | - |
| 01.12.2020 | Endomag secures £15 million ($20 million) in Series D funding | Endomag secures £15 million ($20 million) in Series D funding
01-12-2020
Endomag, a breast cancer market leader and one of the UK’s fastest growing private technology businesses1, has secured £15m (~$20m) in Series D funding. These funds ar... |
| 30.11.2020 | Endomag Raises £15M in Series D Funding | Endomag, a Cambridge, England, UK-based developer of tech solutions for breast cancer, secured £15m (approx. $20m) in Series D funding.
The round, which brought total funding to over £32m (approx. $43m), was led by Draper Esprit with partic... |
| 30.11.2020 | UK medtech startup Endomag raises £15 million to scale its non-invasive approach to breast cancer | Endomag, a Cambridge-based startup developing technology to help simplify breast cancer treatments, has raised £15 million in new cash led by Draper Esprit. The Series D round, which brings the company’s total funding to over £32 million, w... |
| 30.11.2020 | Daily funding roundup - Nov 30th, 2020 | Mursion has raised $20M; Materialize landed $32M; Kinaset secured $40M
Salut: Salut is a San Francisco-based app-based service that allows fitness trainers to host classes virtually. Salut has raised $1.25 million in seed funding led by Pre... |
| 30.11.2020 | UK HealthTech startup Endomag raises $20M in Series D funding to provide better breast cancer care to women around the world | Endomag, a Cambridge, England-based HealthTech startup that provides technologies to help women with breast cancer avoid surgery when it isn’t needed, today announced it has closed £15m (about $20m) in Series D funding. The round was led by... |
| 08.11.2019 | Cambridge companies recognised at industry leading OBN Awards 2019 event | Cambridge companies recognised at industry leading OBN Awards 2019 event
08-11-2019
Cambridge Network members Bicycle Therapeutics and Endomag have been honoured at the 2019 OBN Awards, which celebrate the best of UK life sciences.
OBN (UK)... |
| 01.08.2018 | Breast cancer device receives FDA approval | Breast cancer device receives FDA approval
01-08-2018
Endomag, the surgical guidance company, announced that it has received premarket approval (PMA) from the US Food and Drug Administration (FDA) for Magtrace, the first non-radioactive, du... |
| 01.08.2018 | Breast cancer device receives FDA approval | Endomag, the surgical guidance company, announced that it has received premarket approval (PMA) from the US Food and Drug Administration (FDA) for Magtrace, the first non-radioactive, dual-tracer for lymphatic mapping in patients with breas... |
| 23.07.2018 | Endomag raises $10 million USD (£8M GBP) to establish a new standard of breast cancer care | Endomag raises $10 million USD (£8M GBP) to establish a new standard of breast cancer care
23-07-2018
Surgical guidance company, Endomagnetics Ltd (Endomag), today announced that it has raised $10 million USD (£8M GBP) Series C funding, led... |
| 23.07.2018 | Endomag raises $10 million USD (£8M GBP) to establish a new standard of breast cancer care | Surgical guidance company, Endomagnetics Ltd (Endomag), today announced that it has raised $10 million USD (£8M GBP) Series C funding, led by Draper Esprit. This investment brings total funding for Endomag to over $22 million USD (£17m GBP)... |
| 24.01.2017 | UCSF first to adopt Magseed as standard of care for localization of impalpable breast lesions | UCSF first to adopt Magseed as standard of care for localization of impalpable breast lesions
24-01-2017
Endomag, the cancer healthcare company, announced that the University of California, San Francisco (UCSF) has become the first US site ... |
| 28.01.2015 | Endomag’s Sentimag® trial begins in the US | Endomag’s Sentimag® trial begins in the US
28-01-2015
Endomag, the cancer healthcare company, has announced the completion of the first procedures in the USA using its Sentimag® and Sienna+® system for staging breast cancer, marking the sta... |
| 11.12.2014 | Endomagnetics becomes Endomag as business expands into new markets | Endomagnetics becomes Endomag as business expands into new markets
11-12-2014
Endomagnetics is today revealing a new brand identity that accurately reflects its position as a global leader in the development of devices for cancer care based... |
| 11.12.2014 | Endomagnetics becomes Endomag as business expands into new markets | Endomagnetics is today revealing a new brand identity that accurately reflects its position as a global leader in the development of devices for cancer care based on the application of advanced magnetic technologies.
The identity for newly ... |
| - | The benefits of offering your product for free | Tech companies offering free trials is nothing new. A free trial has long been a great way to introduce your product to potential customers, and hopefully, they’ll then like it enough to start paying for it when the trial ends. At the start... |
